N Jayakumar of Prime Securities believes India is attracting substantial investment due to its strong foundation. He estimates significant HNI positions have been cleared. Institutional investors are consistently buying, preventing market dips below 24,000. Mark Mobius shows interest in Indian pharmaceuticals. A global shift away from US exceptionalism is occurring.
Motilal Oswal initiates coverage on Adani Enterprises with Buy, sees 25% upside. Here’s why
Motilal Oswal has initiated coverage on Adani Enterprises with a Buy rating and a target price of Rs 3,880, implying 25% upside from the prevailing